Literature DB >> 9758759

Expression and ligand binding assays of soluble cytokine receptor-immunoglobulin fusion proteins.

S J Brown1, K A Becherer, K Blumeyer, C Kautzer, F Axelrod, H Le, S J McConnell, A Whalley, D G Spinella.   

Abstract

We have developed a cloning vector for the expression of type I cytokine receptor, NO, extracellular domain (ECD)-mouse IgG1 Fc fusion proteins. The vector has a versatile polylinker that allows in-frame cloning of the receptor ECD with the mouse IgG1 sequence to encode a receptor ECD-IgG1 fusion construct. The receptor-IgG1 fusion proteins are transiently expressed in useful amounts following transfection of the expression vector into COS7 cells and G418 selection. The mouse IgG1 portion of the fusion protein provides a universal handle for purification on an affinity matrix and detection by anti-mouse IgG antibodies in ELISA or Western blot formats. The expressed receptor ECD-IgG1 fusion proteins bind their cognate ligands. In order to demonstrate that the fusion proteins have similar ligand binding affinities as the native receptors, the affinity constants (Kd) for EPOR, TNFR, IL-4R, and IL-6R-IgG1 fusion proteins were measured by surface plasmon resonance and shown to be in good agreement with published values. The TNFR-IgG1 fusion protein was employed in a demonstration of a novel ELISA format for detecting cytokine receptor binding to cytokine. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9758759     DOI: 10.1006/prep.1998.0940

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Ligand-receptor binding measured by laser-scanning imaging.

Authors:  P Zuck; Z Lao; S Skwish; J F Glickman; K Yang; J Burbaum; J Inglese
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  A hingeless Fc fusion system for site-specific cleavage by IdeS.

Authors:  Shabazz Novarra; Luba Grinberg; Keith W Rickert; Arnita Barnes; Susan Wilson; Manuel Baca
Journal:  MAbs       Date:  2016-05-21       Impact factor: 5.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.